TickerFactsScreenerDevelopers

NOVAVAX INC (NVAX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $26.94M2009: $38.76M2010: $8.06M2011: $14.10M2012: $17.40M2013: $119.47M2014: $32.34M2015: $93.11M2016: $144.35M2017: $106.31M2018: $70.15M2019: $78.82M2020: $553.40M2021: $1.52B2022: $1.34B2023: $568.50M2024: $530.23M2025: $240.63M$240.63M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$240.63M-54.6%
2024$530.23M-6.7%
2023$568.50M-57.5%
2022$1.34B-11.8%
2021$1.52B+173.8%
2020$553.40M+602.1%
2019$78.82M+12.4%
2018$70.15M-34.0%
2017$106.31M-26.4%
2016$144.35M+55.0%
2015$93.11M+187.9%
2014$32.34M-72.9%
2013$119.47M+586.7%
2012$17.40M+23.4%
2011$14.10M+75.0%
2010$8.06M-79.2%
2009$38.76M+43.9%
2008$26.94M—